Fig. 2: Prevalence of conditions and medication use among COVID-19 patients. | Nature Communications

Fig. 2: Prevalence of conditions and medication use among COVID-19 patients.

From: Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study

Fig. 2

Individuals hospitalised with COVID-19 between December 2019 and April 2020. Conditions from up to a year prior, medication use from day of hospitalisation. Each dot represents one of these covariates with the colour indicating the type of condition/medication. CUIMC: Columbia University Irving Medical Center; HIRA: Health Insurance Review & Assessment; HM: HM Hospitales; PHD: Premier Healthcare Database; SIDIAP: The Information System for Research in Primary Care; UC HDC: University of Colorado Health Data Compass; VA OMOP: Department of Veterans Affairs.

Back to article page